2016 Fiscal Year Final Research Report
Utility of direct oral anticoagulant in the treatment of acute phase cerebral embolism
| Project/Area Number |
26461318
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Neurology
|
|---|
| Research Institution | Osaka City University |
|---|
Principal Investigator |
Itoh Yoshiaki 大阪市立大学, 大学院医学研究科, 教授 (90265786)
|
|---|
| Project Period (FY) |
2014-04-01 – 2017-03-31
|
| Keywords | 心原性脳塞栓症 |
|---|
| Outline of Final Research Achievements |
The current in vivo study demonstrated that Direct Oral AntiCoagulant (DOAC), clinically used for prevention of cardioembolism from nonvalvular atrial fibrillation, is effective in accelerating recirculation and in reducing the size of cerebral infarction. Clinically cases treated with DOACs not only have less cerebral infarction but also smaller size and lighter sequels. The current data proved the pathophysiology.
|
| Free Research Field |
神経内科
|
